Related Experiment Videos
Phenelzine in social phobia.
Journal of Clinical Psychopharmacology
|April 1, 1986
Summary
Phenelzine shows promise for social phobia treatment. Open trials indicate significant improvement in most patients, suggesting a direct effect on reducing interpersonal hypersensitivity.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Social phobia, a common anxiety disorder, significantly impairs social functioning.
- Current treatments for social phobia have varying efficacy and side effect profiles.
Purpose of the Study:
- To investigate the efficacy of phenelzine in treating social phobia.
- To assess the impact of phenelzine on interpersonal hypersensitivity in social phobia patients.
Main Methods:
- Open-label clinical trial involving 11 patients diagnosed with social phobia according to DSM-III criteria.
- Administration of phenelzine to all participants.
- Assessment of treatment response and interpersonal hypersensitivity.
Main Results:
- Seven out of 11 patients (63.6%) experienced marked improvement in social phobia symptoms.
- The remaining four patients (36.4%) reported moderate benefits from phenelzine treatment.
- Preliminary evidence suggests phenelzine may directly reduce interpersonal hypersensitivity.
Conclusions:
- Phenelzine appears to be an effective treatment option for social phobia, offering significant benefits to a majority of patients.
- The drug's ability to reduce interpersonal hypersensitivity warrants further investigation in controlled studies.
- These findings support the need for replication in larger, randomized controlled trials to confirm efficacy and safety.